TBK1 and amyotrophic lateral sclerosis: 2014) and Sanger sequencing is required for confirmation. If the deletion variant is confirmed, current evidence on the TBK1 deletion variant profile across multiethnic ALS and/or FTD cohorts suggests this could be pathogenic (Cirulli et al. 2015; Oakes et al. 2017).